An additional objective was to investigate whether polymorphisms in the GSTO1 gene, in conjunction with variants of the catalytic subunit of the glutamate cysteine ligase (GCLC) gene—which encodes the first enzyme in the cellular glutathione (GSH) biosynthetic pathway—contribute to a polygenic predisposition to psoriasis. This evidence concerns the gene GCLC and psoriasis.